EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer
Clinical trial NCT00129935 · COMPLETED
Trial details
- NCT number
- NCT00129935
- Sponsor
- Spanish Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2013-06-01
- Enrollment
- 1384
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.